Promising cancer news this morning. Research and development will take five to 10 years, but doctors say this newly developed blood test could detect a single cancer cell, and revolutionize how they detect and treat the deadly disease.
Monday, Johnson and Johnson announced that it will partner with Massachusetts General Hospital to develop and market the blood test. Researchers hope the test will be used by oncologists as a diagnostic tool aimed at discovering cancer that has spread and by researchers in developing new drug therapies.
Today on American Morning, Kiran Chetry talks to Dr. Otis Brawley, chief medical officer, American Cancer Society, about how major the breakthrough is, and who the test could help.